FR2433944A1 - PHARMACEUTICAL FORMULATIONS AND COMPOSITIONS FOR THE TREATMENT OF ALLANTOIN-BASED WOUNDS - Google Patents

PHARMACEUTICAL FORMULATIONS AND COMPOSITIONS FOR THE TREATMENT OF ALLANTOIN-BASED WOUNDS

Info

Publication number
FR2433944A1
FR2433944A1 FR7913695A FR7913695A FR2433944A1 FR 2433944 A1 FR2433944 A1 FR 2433944A1 FR 7913695 A FR7913695 A FR 7913695A FR 7913695 A FR7913695 A FR 7913695A FR 2433944 A1 FR2433944 A1 FR 2433944A1
Authority
FR
France
Prior art keywords
allantoin
treatment
compositions
pharmaceutical formulations
wounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7913695A
Other languages
French (fr)
Other versions
FR2433944B1 (en
Inventor
Douwe Jan Van Linge
Huibert Adriaan Van Riessen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ACF Chemiefarma NV
Original Assignee
ACF Chemiefarma NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ACF Chemiefarma NV filed Critical ACF Chemiefarma NV
Publication of FR2433944A1 publication Critical patent/FR2433944A1/en
Application granted granted Critical
Publication of FR2433944B1 publication Critical patent/FR2433944B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/60Fish, e.g. seahorses; Fish eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/47Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Abstract

La présente invention concerne des formulations et des compositions pharmaceutiques pour le traitement des plaies chez l'homme et l'animal. Elles comprennent, à titre de principes actifs, au moins de l'allantoïne ou un dérivé de l'allantoïne et de l'huile de foie de morue, ou au moins de l'allantoïne ou un dérivé de l'allantoïne et du baume du Pérou. Application : traitement des plaies.The present invention relates to pharmaceutical formulations and compositions for the treatment of wounds in humans and animals. They include, as active ingredients, at least allantoin or a derivative of allantoin and cod liver oil, or at least allantoin or a derivative of allantoin and balsam. Peru. Application: wound treatment.

FR7913695A 1978-05-30 1979-05-29 PHARMACEUTICAL FORMULATIONS AND COMPOSITIONS FOR THE TREATMENT OF ALLANTOIN-BASED WOUNDS Granted FR2433944A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7805855A NL189650C (en) 1978-05-30 1978-05-30 PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF WOUNDS.

Publications (2)

Publication Number Publication Date
FR2433944A1 true FR2433944A1 (en) 1980-03-21
FR2433944B1 FR2433944B1 (en) 1983-03-18

Family

ID=19830946

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7913695A Granted FR2433944A1 (en) 1978-05-30 1979-05-29 PHARMACEUTICAL FORMULATIONS AND COMPOSITIONS FOR THE TREATMENT OF ALLANTOIN-BASED WOUNDS

Country Status (5)

Country Link
BE (1) BE876595A (en)
DE (1) DE2922012A1 (en)
FR (1) FR2433944A1 (en)
GB (1) GB2028130B (en)
NL (1) NL189650C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2151454A1 (en) * 1999-05-06 2000-12-16 Szlec Christopher Dura Salve for anal inflammation contains a zinc oxide based aid

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4322956C2 (en) * 1993-07-09 1995-12-21 Haack Karl Werner An Chitosan film for wound sealing
AR062835A1 (en) * 2007-08-29 2008-12-10 Walter Montagni A SELECTIVE STIMULATING COMPOSITION OF CICATRIZATION ITS PREPARATION AND APPLICATION

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2151454A1 (en) * 1999-05-06 2000-12-16 Szlec Christopher Dura Salve for anal inflammation contains a zinc oxide based aid

Also Published As

Publication number Publication date
GB2028130B (en) 1982-12-15
FR2433944B1 (en) 1983-03-18
NL7805855A (en) 1979-12-04
GB2028130A (en) 1980-03-05
NL189650B (en) 1993-01-18
NL189650C (en) 1993-06-16
BE876595A (en) 1979-11-29
DE2922012A1 (en) 1979-12-06

Similar Documents

Publication Publication Date Title
CA2330500A1 (en) Pharmaceutical compositions capable of being gelled
FR2347044A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING, AS ACTIVE INGREDIENTS, TRIAZOLO-PYRIMIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF PSORIASIS
ATE123943T1 (en) AGENTS FOR THE TREATMENT AND PREVENTION OF ABDOMINAL INFLAMMATION WHICH CONTAIN ZINC-L-CARNOSINE SALTS OR COMPLEXES AS THE ACTIVE INGREDIENTS.
ATE61050T1 (en) PYRIDAZINAMINES EFFECTIVE AGAINST VIRUSES.
PT750618E (en) OXAZOLIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
BE854414A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BENIGN HYPERTROPHIA OF PROSTATE
ATE218868T1 (en) ANTICOUGH COMPOSITIONS CONTAINING THEOBROMINES
ATE15596T1 (en) PHARMACEUTICAL AGENT.
FI914409A0 (en) CALCIUMUPPTAGANDE INHIBITORER.
BE900564A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES.
FR2541115B1 (en) MEDICAMENT CONTAINING PEPTIDE AS ACTIVE INGREDIENT FOR THE TREATMENT OF ULCEROUS CONDITIONS
FR2433944A1 (en) PHARMACEUTICAL FORMULATIONS AND COMPOSITIONS FOR THE TREATMENT OF ALLANTOIN-BASED WOUNDS
ES511962A0 (en) "PROCEDURE FOR THE PREPARATION OF COMPOSITIONS OF ALDEHYDIC FERORMONES FOR SLOW RELEASE OF THE ACTIVE COMPOUND".
DE58903964D1 (en) LIQUID ORAL FORMULATION.
BE887639A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
BE872908A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION
ATE110714T1 (en) HYDROXAMIC ACID DERIVATIVES WHICH INHIBIT LIPOXYGENASE.
ATE274905T1 (en) 4,5-DIHYDROXY-2-CYCLOPENTENE-1-ONE FOR THE TREATMENT OF RHEUMATISM, INFLAMMATION AND AUTOIMMUNE DISEASES
BE902055A (en) PHARMACEUTICAL PREPARATIONS.
FR2437832A1 (en) MEDICAMENT BASED ON P-TOLYL DIIODOMETHYLSULFONE USEFUL IN PARTICULAR FOR THE TREATMENT OF SKIN INFECTIONS CAUSED BY YEAST AND MUSHROOMS
FR2380778A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING SUBSTITUTE OXANILIC ACIDS OR THEIR ESTERS
BE900186A (en) SYNERGISTIC FUNGICIDE COMPOSITIONS.
BE899867A (en) ANTIHYPERLIPIDEMIA COMPOSITION BASED ON DILTIAZEM.
FI914410A0 (en) CALCIUMUPPTAGANDE INHIBITORER.
ES2102370T3 (en) ANTIPARASITIC COMPOSITION FOR ANIMAL USE.

Legal Events

Date Code Title Description
ST Notification of lapse